B, B, H, & B Inc’s Medtronic MDT Stock Holding History

B, B, H, & B Inc’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-248	Closed	-$29K	–	92
2020 Q4	$29K	Buy	+248	New	+$27.3K	0.03%	72

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

B, B, H, & B Inc's MDT Position: Q1 2021 in Review

B, B, H, & B Inc sold out of Medtronic (MDT) in Q1 2021, closing a stake of 248 shares — an estimated $29K sold.

B, B, H, & B Inc first reported a position in MDT in Q4 2020 and held it in 1 quarter. The position peaked at $29K in Q4 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

B, B, H, & B Inc reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
B, B, H, & B Inc sold 248 Medtronic shares in Q1 2021, an estimated $29K.
B, B, H, & B Inc first reported a position in Medtronic in Q4 2020 and held it in 1 quarter.
B, B, H, & B Inc's Medtronic position peaked at $29K in Q4 2020.
1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on B, B, H, & B Inc's 13F filing for Q1 2021, filed 11 May 2021.